These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21564529)

  • 1. Should metformin be our antiglycemic agent of choice post-transplantation?
    Sharif A
    Am J Transplant; 2011 Jul; 11(7):1376-81. PubMed ID: 21564529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin in patients with chronic kidney disease: strengths and weaknesses.
    Rocha A; Almeida M; Santos J; Carvalho A
    J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HYPERGLYCEMIA MANAGEMENT IN PATIENTS WITH POSTTRANSPLANTATION DIABETES.
    Galindo RJ; Fried M; Breen T; Tamler R
    Endocr Pract; 2016 Apr; 22(4):454-65. PubMed ID: 26720253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and vascular protection: a cardiologist's view.
    Libby P
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S117-20. PubMed ID: 14502109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):196-205. PubMed ID: 25772174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.
    Fruci B; Giuliano S; Mazza A; Malaguarnera R; Belfiore A
    Int J Mol Sci; 2013 Nov; 14(11):22933-66. PubMed ID: 24264040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: An Old Drug with New Applications.
    Zhou J; Massey S; Story D; Li L
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
    Després JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapy of insulin resistance in other diseases besides type 2 diabetes.
    Pala L; Barbaro V; Dicembrini I; Rotella CM
    Eat Weight Disord; 2014; 19(3):275-83. PubMed ID: 25069836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD).
    Doycheva I; Loomba R
    Adv Ther; 2014 Jan; 31(1):30-43. PubMed ID: 24385405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes.
    Henry RR
    Clin Ther; 2003; 25 Suppl B():B47-63. PubMed ID: 14553866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.
    Tahara A; Takasu T
    Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is metformin more than an oral hypoglycaemic agent?
    Vague P
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S5-7. PubMed ID: 14502095
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin: an update.
    Kirpichnikov D; McFarlane SI; Sowers JR
    Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.
    Nar A; Gedik O
    Acta Diabetol; 2009 Jun; 46(2):113-8. PubMed ID: 18839053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type 2 diabetes: role of metformin.
    Charles MA; Eschwège E
    Drugs; 1999; 58 Suppl 1():71-3; discussion 75-82. PubMed ID: 10576529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium.
    Zsóri G; Illés D; Ivány E; Kosár K; Holzinger G; Tajti M; Pálinkás E; Szabovik G; Nagy A; Palkó A; Czakó L
    Metab Syndr Relat Disord; 2019 Jun; 17(5):289-295. PubMed ID: 31013454
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
    Palumbo PJ
    J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.